Gregory Idos

6PUBLICATIONS
39CO-AUTHORS
Molecular evolutionPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2026
Bayesian Integration of Tumor Mutational Signatures and Somatic Features Refines Pathogenicity Assessment of Germline Mismatch Repair Variants.

|Aug 26, 2026
Age-Specific Ovarian Cancer Risk Among Individuals With Pathogenic Variants in PALB2.

|Apr 08, 2026
Sex Differences in Colorectal Tumor-Associated T-cell Responses.

Elizabeth Seitz, Ya-Yu Tsai, Rebeca Sanz-Pamplona

|May 17, 2024
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.

Nadine Tung, Charité Ricker, Hans Messersmith

|Sep 24, 2020
Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.

Rebeca Sanz-Pamplona, Marilena Melas, Asaf Maoz

|Feb 27, 2020
The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Gregory E Idos, Janet Kwok, Nirupama Bonthala

Pageof 1

Frequent Collaborators

3 joint publications

Stephen B Gruber

2 joint publications

Rebeca Sanz-Pamplona

2 joint publications

Stephanie L Schmit

2 joint publications

Gad Rennert